Загрузка...
Lobaplatin for the treatment of SK-MES-1 lung squamous cell line in vitro and in vivo
Lung squamous cell carcinoma is the second-largest histological subtype of lung cancer, which is the leading cause of cancer-related death worldwide. Lobaplatin, one of the third-generation platinum compounds, has shown encouraging anticancer activity in a variety of tumors. The aim of this study wa...
Сохранить в:
Опубликовано в: : | Onco Targets Ther |
---|---|
Главные авторы: | , , , , , , , |
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
Dove Medical Press
2016
|
Предметы: | |
Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4948715/ https://ncbi.nlm.nih.gov/pubmed/27471396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S108032 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|